NCT02326428 - SITS (Safe Implementation of Treatments in Stroke) Open Artery by Thrombectomy in Acute Occlusive Stroke Study | Biotech Hunter

Enrollment

341

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Ischemic Stroke

Interventions

DEVICE

Stent retriever endovascular device for thrombectomy

Thrombectomy by selected stent retrievers (TREVO, Solitaire, pREset, in special cases all stent retrievers) as additional therapy in major artery occlusion in patients fulfilling criteria for and receiving intravenous thrombolysis

DRUG

Intravenous thrombolysis by alteplase (Actilyse) (optional)

Stroke thrombolysis with Alteplase (Boeringer-Ingelheim, ATC-code B01AD02; a fibrinolytic drug) according to conventional guidelines (0.9 mg/kg, not exceeding 90 mg, given intravenously)

Trial Locations (1)

17176

Karolinska University Hospital, Stockholm